Andrew M Intlekofer

12PUBLICATIONS
98CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 29, 2026
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.

|Dec 11, 2024
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma.

Pallawi Torka, Tatyana Feldman, Kerry J Savage

|Jun 19, 2023
A multimodal atlas of tumour metabolism reveals the architecture of gene-metabolite covariation.

Elisa Benedetti, Eric Minwei Liu, Cerise Tang

|Jun 22, 2022
Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hürthle cell carcinoma.

Ian Ganly, Eric Minwei Liu, Fengshen Kuo

|Dec 24, 2021
GCN2 kinase activation by ATP-competitive kinase inhibitors.

Colin P Tang, Owen Clark, John R Ferrarone

|Jun 25, 2021
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.

Alison J Moskowitz, Gunjan Shah, Heiko Schöder

Pageof 2

Frequent Collaborators

5 joint publications

Ahmet Dogan

4 joint publications

Anita Kumar

4 joint publications

Santosha Vardhana

4 joint publications

Steven M Horwitz